cabazitaxel use in metastatic prostate cancer
Published 8 years ago • 2.8K plays • Length 7:09Download video MP4
Download video MP3
Similar videos
-
1:04
dr. grivas on potential combinations with cabazitaxel in prostate cancer
-
1:37
cabazitaxel rechallenge in patients with metastatic castration resistant prostate cancer
-
3:13
treatment options in metastatic prostate cancer
-
1:30
cabazitaxel impacts sequencing strategies in prostate cancer
-
3:12
cabazitaxel (jevtana) for progressive metastatic prostate cancer after taxotere
-
4:06
combination of abiraterone and cabazitaxel in metastatic castration-resistant prostate cancer
-
5:56
card trial in metastatic crpc
-
1:53
nicholas vogelzang, md, explains how cabazitaxel should be used in various lines of treatment in mpc
-
6:16
evolution of treatment for metastatic castration-resistant prostate cancer
-
0:34
jevtana’s toxicity profile makes it a good option in metastatic prostate cancer
-
1:17
dr kyriakopoulos on adding cabazitaxel to abiraterone/prednisone in patients with mcrpc
-
1:22
cabazitaxel improves rpfs in patients with mcrpc
-
3:47
cabazitaxel safe and effective in mcrpc
-
4:34
card: cabazitaxel vs abiraterone or enzalutamide in metastatic castration-resistant prostate cancer
-
3:16
counseling patients with mcrpc
-
1:52
treatment sequencing in mcrpc: cabazitaxel vs. abiraterone or enzalutamide
-
4:50
card trial: cabazitaxel after ar-targeted therapy in mcspc
-
4:06
changes in nccn guideline: affecting first-line
-
9:41
jevtana® (cabazitaxel) mechanism of action